Andrew Makrides
Founder at APYX MEDICAL CORPORATION
Net worth: 849 169 $ as of 2024-03-30
Profile
Andrew Makrides founded Apyx Medical Corp.
in 1978, where he is working as Executive Chairman from 2013.
Mr. Makrides also currently works at New York State Bar Association, as Member from 1968.
Mr. Makrides received his undergraduate degree from Hofstra University and graduate degree from Brooklyn Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
APYX MEDICAL CORPORATION
1.80% | 2023-08-09 | 624,389 ( 1.80% ) | 849 169 $ | 2024-03-30 |
Andrew Makrides active positions
| Companies | Position | Start |
|---|---|---|
| APYX MEDICAL CORPORATION | Founder | 1977-12-31 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | 1967-12-31 |
Training of Andrew Makrides
| Hofstra University | Undergraduate Degree |
| Brooklyn Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APYX MEDICAL CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
- Stock Market
- Insiders
- Andrew Makrides
